What are the causes of fatigue after cancer treatment?
Marije van der Lee
Hereditary leukemias – clinical implications
Jane E. Churpek
Benefits of early therapeutic intervention for high-risk smouldering multiple myeloma patients
An update on two trials evaluating venetoclax in subsets of CLL
Do immunoglobulin receptor interactions play a role in CLL?